Candel Therapeutics Inc. (CADL) NASDAQ
$5.54 0.37 (7.16%)
Market Cap: $162.58M
As of 04/22/24 04:00 PM EDT. Market closed.
Candel Therapeutics Inc. (CADL)
NASDAQ
$5.54
0.37 (7.16%)
Market Cap: $162.58M
As of 04/22/24 04:00 PM EDT. Market closed.
Add to Portfolio
also known as advantagene. inc., we are a massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our gene mediated cytotoxic (gmci™) platform and our rqnestin34.5 platform. gmci™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
88
URL
Address
.
PRICE CHART FOR CANDEL THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$5.17
Days Range
$5.10 - $5.68
52 week range
$0.66 - $11.40
Volume
11,352
Avg. Volume (30 days)
17,240,751
Market Cap
$162.58M
Dividend Yield
-
P/E
(5.09)
Shares Outstanding
29,347,468
Open
-
Previous Close
$5.17
Days Range
$5.10 - $5.68
52 week range
$0.66 - $11.40
Volume
11,352
Avg. Volume (30 days)
17,240,751
Market Cap
$162.58M
Dividend Yield
-
P/E
(5.09)
Shares Outstanding
29,347,468
FINANCIAL STATEMENTS FOR CANDEL THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR CANDEL THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Tyagarajan Seshu | Chief Technology Officer | Nov 28, 2023 | Option Exercise | $0.90 | 17,328 | 15,595 | 174,230 | Nov 30, 2023, 05:00 PM |
Tak Paul Peter | Chief Executive Officer | Nov 28, 2023 | Option Exercise | $0.90 | 43,443 | 39,099 | 373,556 | Nov 30, 2023, 05:00 PM |
Nichols William Garrett | Chief Medical Officer | Nov 28, 2023 | Option Exercise | $0.90 | 12,175 | 10,957 | 135,126 | Nov 30, 2023, 05:00 PM |
Barone Francesca | Chief Scientific Officer | Nov 28, 2023 | Option Exercise | $0.90 | 19,748 | 17,773 | 186,657 | Nov 30, 2023, 05:00 PM |
Amello Jason | Chief Financial Officer | Nov 28, 2023 | Option Exercise | $0.90 | 20,153 | 18,138 | 202,009 | Nov 30, 2023, 05:00 PM |
Martell Christopher | Director | Dec 09, 2022 | Buy | $1.92 | 23,950 | 45,984 | 152,000 | Feb 17, 2023, 06:40 PM |
Martell Christopher | Director | Dec 08, 2022 | Buy | $1.68 | 3,050 | 5,124 | 128,050 | Feb 17, 2023, 06:40 PM |
Barone Francesca | Chief Scientific Officer | Dec 08, 2022 | Buy | $1.61 | 1,238 | 1,993 | 2,738 | Dec 12, 2022, 04:30 PM |
PAPA JOSEPH C | Director | Dec 09, 2022 | Buy | $1.94 | 35,018 | 67,935 | 38,032 | Dec 12, 2022, 04:25 PM |
PAPA JOSEPH C | Director | Dec 08, 2022 | Buy | $1.70 | 3,014 | 5,124 | 3,014 | Dec 12, 2022, 04:25 PM |
Martell Christopher | Director | Dec 09, 2022 | Buy | $1.92 | 23,950 | 45,984 | 152,000 | Dec 12, 2022, 04:25 PM |
Martell Christopher | Director | Dec 08, 2022 | Buy | $1.68 | 3,050 | 5,124 | 128,050 | Dec 12, 2022, 04:25 PM |
Tak Paul Peter | Chief Executive Officer | Dec 09, 2022 | Buy | $1.92 | 12,935 | 24,835 | 40,985 | Dec 12, 2022, 04:25 PM |
Tak Paul Peter | Chief Executive Officer | Dec 08, 2022 | Buy | $1.70 | 3,050 | 5,185 | 28,050 | Dec 12, 2022, 04:25 PM |
Tyagarajan Seshu | Chief Technology Officer | Dec 08, 2022 | Buy | $1.69 | 3,000 | 5,070 | 3,000 | Dec 12, 2022, 04:25 PM |
Tyagarajan Seshu | Chief Technology Officer | Dec 09, 2022 | Buy | $1.93 | 10,358 | 19,991 | 13,358 | Dec 12, 2022, 04:25 PM |
Amello Jason | Chief Financial Officer | Dec 09, 2022 | Buy | $1.93 | 2,468 | 4,763 | 5,568 | Dec 12, 2022, 04:25 PM |
Amello Jason | Chief Financial Officer | Dec 08, 2022 | Buy | $1.69 | 3,100 | 5,239 | 3,100 | Dec 12, 2022, 04:25 PM |
Aguilar Laura K. | 10% Owner | May 06, 2022 | Option Exercise | $3.65 | 68,534 | 250,149 | 1,033,840 | May 10, 2022, 06:07 PM |
Aguilar Laura K. | 10% Owner | May 06, 2022 | Option Exercise | $1.46 | 171,335 | 250,149 | 1,102,374 | May 10, 2022, 06:07 PM |
Aguilar-Cordova Estuardo | Director | May 06, 2022 | Option Exercise | $3.65 | 54,074 | 197,370 | 1,097,032 | May 10, 2022, 06:04 PM |
Aguilar-Cordova Estuardo | Director | May 06, 2022 | Option Exercise | $1.46 | 135,183 | 197,367 | 1,151,106 | May 10, 2022, 06:04 PM |
Manning Paul B | Director | Jul 29, 2021 | Buy | $8.00 | 1,625,000 | 13,000,000 | 1,681,000 | Aug 04, 2021, 04:41 PM |
Martell Christopher | Director | Jul 29, 2021 | Buy | $8.00 | 125,000 | 1,000,000 | 125,000 | Aug 02, 2021, 08:12 PM |
Nguyen Diem | Director | Jul 29, 2021 | Buy | $8.00 | 10,000 | 80,000 | 10,000 | Aug 02, 2021, 08:11 PM |
Tak Paul Peter | Chief Executive Officer | Jul 29, 2021 | Buy | $8.00 | 25,000 | 200,000 | 25,000 | Aug 02, 2021, 08:09 PM |
Canepa John J | Chief Financial Officer | Jul 29, 2021 | Buy | $8.00 | 10,125 | 81,000 | 10,125 | Aug 02, 2021, 08:06 PM |
Caffo Nathan | Chief Business Officer | Jul 29, 2021 | Buy | $8.00 | 6,000 | 48,000 | 6,000 | Aug 02, 2021, 08:02 PM |
Manning Paul B | Director | Jul 29, 2021 | Buy | $7.30 | 20,000 | 145,944 | 56,000 | Jul 29, 2021, 09:02 PM |
Manning Paul B | Director | Jul 27, 2021 | Buy | $7.36 | 36,000 | 264,834 | 36,000 | Jul 29, 2021, 09:02 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Tyagarajan Seshu | Chief Technology Officer | 11/28/2023 | 15,595 |
Tak Paul Peter | Chief Executive Officer | 11/28/2023 | 39,099 |
Nichols William Garrett | Chief Medical Officer | 11/28/2023 | 10,957 |
Barone Francesca | Chief Scientific Officer | 11/28/2023 | 17,773 |
Amello Jason | Chief Financial Officer | 11/28/2023 | 18,138 |
Martell Christopher | Director | 12/09/2022 | 45,984 |
Martell Christopher | Director | 12/08/2022 | 5,124 |
Barone Francesca | Chief Scientific Officer | 12/08/2022 | 1,993 |
PAPA JOSEPH C | Director | 12/09/2022 | 67,935 |
PAPA JOSEPH C | Director | 12/08/2022 | 5,124 |
Martell Christopher | Director | 12/09/2022 | 45,984 |
Martell Christopher | Director | 12/08/2022 | 5,124 |
Tak Paul Peter | Chief Executive Officer | 12/09/2022 | 24,835 |
Tak Paul Peter | Chief Executive Officer | 12/08/2022 | 5,185 |
Tyagarajan Seshu | Chief Technology Officer | 12/08/2022 | 5,070 |
Tyagarajan Seshu | Chief Technology Officer | 12/09/2022 | 19,991 |
Amello Jason | Chief Financial Officer | 12/09/2022 | 4,763 |
Amello Jason | Chief Financial Officer | 12/08/2022 | 5,239 |
Aguilar Laura K. | 10% Owner | 05/06/2022 | 250,149 |
Aguilar Laura K. | 10% Owner | 05/06/2022 | 250,149 |
Aguilar-Cordova Estuardo | Director | 05/06/2022 | 197,370 |
Aguilar-Cordova Estuardo | Director | 05/06/2022 | 197,367 |
Manning Paul B | Director | 07/29/2021 | 13,000,000 |
Martell Christopher | Director | 07/29/2021 | 1,000,000 |
Nguyen Diem | Director | 07/29/2021 | 80,000 |
Tak Paul Peter | Chief Executive Officer | 07/29/2021 | 200,000 |
Canepa John J | Chief Financial Officer | 07/29/2021 | 81,000 |
Caffo Nathan | Chief Business Officer | 07/29/2021 | 48,000 |
Manning Paul B | Director | 07/29/2021 | 145,944 |
Manning Paul B | Director | 07/27/2021 | 264,834 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CANDEL THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 139,253 | 0.00002% | No change | Other |
BLACKROCK INC. | 49,285 | 0% | -1.13% | Other |
RENAISSANCE TECHNOLOGIES LLC | 18,675 | 0.00004% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR CANDEL THERAPEUTICS INC
STOCK BUYBACKS FOR CANDEL THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.21%
1Q
06/30/2023
0.21%
2Q
03/31/2023
0.21%
3Q
12/31/2022
0.29%
4Q
09/30/2022
0.31%
5Q
06/30/2022
0.60%
6Q
03/31/2022
1.02%
7Q
12/31/2021
53.56%
8Q
09/30/2021
24.25%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CANDEL THERAPEUTICS INC
LOADING...